Fingerprint
Dive into the research topics of 'Daratumumab-lenalidomide-dexamethasone vs standard-of-care regimens: Efficacy in transplant-ineligible untreated myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Daratumumab-lenalidomide-dexamethasone vs standard-of-care regimens: Efficacy in transplant-ineligible untreated myeloma
Brian G.M. Durie, Shaji K. Kumar, Saad Z. Usmani, Bareng A.S. Nonyane, Eric M. Ammann, Annette Lam, Rachel Kobos, Eric M. Maiese, Thierry Facon
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations